ATRIUM Partners advised DSM on its acquisition of Glycom

In a transaction valued at EUR 765m (EV), ATRIUM Partners acted as exclusive financial advisors to DSM, the global player in the ingredients and materials space, on its acquisition of Glycom, the world’s leading supplier of Human Milk Oligosaccharides (HMO).

Glycom is a Danish, leading developer and manufacturer of Human Milk Oligosaccharides (HMO). HMOs are complex carbohydrates found naturally in breast milk that strengthens the immune system and improves gut flora. Today, HMOs are used in infant formula but the application can be extended to other areas. Through this transaction, Glycom becomes part of DSM’s Human Nutrition & Health division, strengthening DSM’s market position. ATRIUM Partners’ market knowledge and network created positive momentum in the process and valuable insights for DSM which were applied for strategic pricing and positioning.


ATRIUM Partners

Advised in the sale of

Glycom A/S


DSM Group


MidCap Alliance